QCM Cayman’s Elevance Health ELV Stock Holding History

QCM Cayman’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-2,800	Closed	-$229K	–	186
2013 Q2	$229K	Buy	+2,800	New	+$210K	0.17%	97

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

QCM Cayman's ELV Position: Q4 2017 in Review

QCM Cayman sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 2,514 shares — an estimated $477K sold.

QCM Cayman first reported a position in ELV in Q1 2014 and held it in 3 quarters. The position peaked at $595K in Q1 2014. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

QCM Cayman reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
QCM Cayman sold 2,514 Elevance Health shares in Q4 2017, an estimated $477K.
QCM Cayman first reported a position in Elevance Health in Q1 2014 and held it in 3 quarters.
QCM Cayman's Elevance Health position peaked at $595K in Q1 2014.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on QCM Cayman's 13F filing for Q4 2017, filed 14 Feb 2018.